Download MendeleyElectrostatically-guided inhibition of Curli amyloid nucleation by the CsgC-like family of chaperones.
Taylor, J.D., Hawthorne, W.J., Lo, J., Dear, A., Jain, N., Meisl, G., Andreasen, M., Fletcher, C., Koch, M., Darvill, N., Scull, N., Escalera-Maurer, A., Sefer, L., Wenman, R., Lambert, S., Jean, J., Xu, Y., Turner, B., Kazarian, S.G., Chapman, M.R., Bubeck, D., de Simone, A., Knowles, T.P., Matthews, S.J.(2016) Sci Rep 6: 24656-24656
- PubMed: 27098162
- DOI: https://doi.org/10.1038/srep24656
- Primary Citation of Related Structures:
2N59 - PubMed Abstract:
Polypeptide aggregation into amyloid is linked with several debilitating human diseases. Despite the inherent risk of aggregation-induced cytotoxicity, bacteria control the export of amyloid-prone subunits and assemble adhesive amyloid fibres during biofilm formation. An Escherichia protein, CsgC potently inhibits amyloid formation of curli amyloid proteins. Here we unlock its mechanism of action, and show that CsgC strongly inhibits primary nucleation via electrostatically-guided molecular encounters, which expands the conformational distribution of disordered curli subunits. This delays the formation of higher order intermediates and maintains amyloidogenic subunits in a secretion-competent form. New structural insight also reveal that CsgC is part of diverse family of bacterial amyloid inhibitors. Curli assembly is therefore not only arrested in the periplasm, but the preservation of conformational flexibility also enables efficient secretion to the cell surface. Understanding how bacteria safely handle amyloidogenic polypeptides contribute towards efforts to control aggregation in disease-causing amyloids and amyloid-based biotechnological applications.
Organizational Affiliation:
Department of Life Sciences, Imperial College London, London, SW7 2AZ, UK.
